Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
The Lancet. Rheumatology|September 23, 2020
Tocilizumab in COVID-19: finding the optimal route and dose - Authors' replyGiovanni Guaraldi, Jovana Milic, Alessandro Cozzi-Lepri, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab for severe COVID-19 pneumonia - Authors' replyGiovanni Guaraldi, Marianna Meschiari, Jovana Milic, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 2, 2020
Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?Antonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
AIDS (London, England)|September 10, 2003
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studiesAndrew N Phillips, Alessandro Cozzi Lepri, Fiona Lampe, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Predictive Factors for Pregnancy-Related Persistent Pelvic Girdle Pain (PPGP): A Systematic ReviewElisa Burani, Sharon Marruganti, Gloria Giglioni, et al.
Journal of Hepatology|December 15, 2005
Multiple viral infectionsGiovanni B Gaeta, Davide F Precone, Alessandro Cozzi-Lepri, et al.
Pharmacological Research|May 23, 2022
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational dataAndrea Giacomelli, Alessandro Cozzi-Lepri, Giacomo Casalini, et al.
AIDS (London, England)|February 20, 2015
Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trialMartyn A French, Alessandro Cozzi-Lepri, Roberto C Arduino, et al.
Open Forum Infectious Diseases|March 7, 2018
Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral TherapyAlessandra Ruggiero, Alessandro Cozzi-Lepri, Apostolos Beloukas, et al.
AIDS (London, England)|April 21, 2011
Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trialAlessandro Cozzi-Lepri, Martyn A French, John Baxter, et al.
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
The Lancet. Rheumatology|September 23, 2020
Tocilizumab in COVID-19: finding the optimal route and dose - Authors' replyGiovanni Guaraldi, Jovana Milic, Alessandro Cozzi-Lepri, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab for severe COVID-19 pneumonia - Authors' replyGiovanni Guaraldi, Marianna Meschiari, Jovana Milic, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 2, 2020
Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?Antonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
AIDS (London, England)|September 10, 2003
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studiesAndrew N Phillips, Alessandro Cozzi Lepri, Fiona Lampe, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Predictive Factors for Pregnancy-Related Persistent Pelvic Girdle Pain (PPGP): A Systematic ReviewElisa Burani, Sharon Marruganti, Gloria Giglioni, et al.
Journal of Hepatology|December 15, 2005
Multiple viral infectionsGiovanni B Gaeta, Davide F Precone, Alessandro Cozzi-Lepri, et al.
Pharmacological Research|May 23, 2022
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational dataAndrea Giacomelli, Alessandro Cozzi-Lepri, Giacomo Casalini, et al.
AIDS (London, England)|February 20, 2015
Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trialMartyn A French, Alessandro Cozzi-Lepri, Roberto C Arduino, et al.
Open Forum Infectious Diseases|March 7, 2018
Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral TherapyAlessandra Ruggiero, Alessandro Cozzi-Lepri, Apostolos Beloukas, et al.
AIDS (London, England)|April 21, 2011
Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trialAlessandro Cozzi-Lepri, Martyn A French, John Baxter, et al.
Pageof 25